Market revenue in 2023 | USD 36.7 million |
Market revenue in 2030 | USD 70.3 million |
Growth rate | 9.7% (CAGR from 2023 to 2030) |
Largest segment | Blood sample |
Fastest growing segment | Blood Sample |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Blood Sample |
Key market players worldwide | ANGLE PLC, Guardant Health Inc, Myriad Genetics Inc, Biocept Inc, Lucence Health, Roche, Qiagen NV, Illumina Inc, Thermo Fisher Scientific Inc, Epigenomics AG, Oncimmune, Freenome |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to liquid biopsy market will help companies and investors design strategic landscapes.
Blood sample was the largest segment with a revenue share of 73.3% in 2023. Horizon Databook has segmented the Saudi Arabia liquid biopsy market based on blood sample covering the revenue growth of each sub-segment from 2018 to 2030.
The growth of Saudi Arabia liquid biopsy market can majorly be attributed to increasing involvement of the government and rising awareness about the benefits of noninvasive diagnostic procedures.
In addition, the rapid advancements in NGS and PCR technologies have improved the accuracy of liquid biopsy over the years. Moreover, local and international market players are focusing on expanding their networks in Saudi Arabia, as awareness and adoption of NGS technologies are increasing in the country.
The NGS platform holds great promise in liquid biopsy as it is a trending technique for CTDNA profiling, and profiling of CTDNA by NGS technologies has gained more traction as it can be applied in the tumor diagnosis process. Such factors are anticipated to drive the market.
Horizon Databook provides a detailed overview of country-level data and insights on the Saudi Arabia liquid biopsy market , including forecasts for subscribers. This country databook contains high-level insights into Saudi Arabia liquid biopsy market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account